Navigation Links
Genomic Health Announces First Quarter 2011 Financial Results and Business Progress
Date:5/3/2011

ctal Cancer, to launch My Colon Cancer Coach, a unique online tool that empowers patients with individualized information to engage in a more knowledgeable dialogue with their healthcare team.
  • Secured access to tumor samples from two large clinical trials to initiate oxaliplatin studies.

  • Product Pipeline, Peer-Reviewed Publications and Medical Meeting Presentations

  • Presented complete results of a prostate cancer gene identification study at the American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancer Symposium and the United States & Canadian Academy of Pathology (USCAP) 2011 meeting.
  • Presented results of nine studies from seven countries at the 12th Annual St. Gallen International Breast Cancer Conference demonstrating chemotherapy reduction and overall cost effectiveness when Oncotype DX is used.
  • Announced launch of RxPONDER S1007 (Rx for Positive Node, Endocrine Responsive Breast Cancer), a large multi-center clinical trial being led by SWOG, one of the largest National Cancer Institute (NCI) supported cancer cooperative groups, to determine the effect of chemotherapy in patients with node-positive breast cancer with Recurrence Score® results equal to, or less than, 25 as determined by the Oncotype DX breast cancer test. This study will seek to enroll 9,000 patients in order to randomize 4,000 patients with Recurrence Score® results equal to, or less than, 25.  
  • The Journal of Oncology Practice published results of a clinical survey in the United States showing use of Oncotype DX changed treatment recommendations more than 40 percent of the time for women with lymph node-positive breast cancer, leading to an overall reduction in chemotherapy.
  • Received acce
    '/>"/>

  • SOURCE Genomic Health, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Transgenomic, Inc. Presentations to Describe High-Sensitivity Detection of Cancer Biomarkers at the 2011 American Association for Cancer Research Meeting
    2. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
    3. Genomic Health Presents Multiple International Studies Demonstrating Worldwide Value of Oncotype DX® Breast Cancer Test
    4. Reminder Webcast Alert: Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    5. Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011
    6. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
    7. Researchers use genomics to investigate TB outbreak
    8. Transgenomic to Present at the Lippert/Heilshorn Life Sciences & Medtech Virtual Conference on February 17
    9. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
    10. Sigma Life Science Collaborates with Cofactor Genomics to Develop Publically Available Rat Genome Database
    11. Four Community Hospitals Join DNA Directs Genomic Medicine Network
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
    (Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
    (Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
    (Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
    Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
    ... positions Company to ... quarter of this year, ROCKVILLE, Md., Sept. 19 ... has completed enrollment of healthy,volunteers in a Phase IIa ... vaccine. The Phase IIa randomized, placebo,controlled clinical trial is ...
    ... Thirty seven medical,experts in psychiatry from across the ... urgent action to optimize services for people with ... or bipolar,disorder(i)., Professor W. Wolfgang Fleischhacker, principal ... Mental Disorders: Clinical,Policy, and Research Challenges which was ...
    ... NEP ),today announced that the Company has received ... indicating that the Company is not in,compliance with certain ... the AMEX Company Guide. Specifically, AMEX noted the,Company,s failure ... relating to stockholders, equity of less than $6,000,000 and ...
    Cached Biology Technology:Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 2Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 3Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial 4Global Psychiatrists Unite to Improve Services in Mental Health 2Global Psychiatrists Unite to Improve Services in Mental Health 3Nephros Receives Non-Compliance Notification from AMEX 2Nephros Receives Non-Compliance Notification from AMEX 3
    (Date:11/21/2014)... 2014 C-Labs LLC, a leading provider of ... (IoT), today announced the appointment of John Traynor ... a strategic advisor to the firm, Mr. Traynor will ... is based out of the C-Labs office in ... Chris Muench , Chief Executive Officer. Photo ...
    (Date:11/18/2014)... -- The Parenteral Drug Association (PDA) today confirmed that seven ... at least seven more will participate in the upcoming 2014 ... in Washington D.C. , Dec. 2-4. ... from the regulatory agencies in the United States ... effort to help advance the use of metrics in the ...
    (Date:11/11/2014)... 11, 2014  Forensicon, Inc., a Chicago ... to announce the promotion of Yaniv Schiff ... Forensics. In Schiff,s new role as Director, he will ... digital forensics examiners and provide leadership within the company,s ... http://photos.prnewswire.com/prnh/20141110/157719 Schiff joined Forensicon ...
    Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Yaniv Schiff Promoted to Director of Digital Forensics at Forensicon, Inc. 2
    ... at the Ruhr-Universitt Bochum (RUB) have launched a new ... in promoting neuronal survival. The team of Prof Dr ... Department of Molecular Cell Biology, is looking for new ... Fox Foundation finances this research project with 125,000 US ...
    ... Discovery Fund (LSDF) today announced $1.1 million in ... and non-profit organizations to foster the translation of ... marketplace. Two of the five new ... invented within Washington-based companies. HeatFlow Technologies (principal investigator ...
    ... Tech leaders close out 2013 with beneficial ... (NASDAQ: SYMC ), Avago Technologies Limited (NASDAQ: ... ) and Apple Inc. (NASDAQ: AAPL) NXT-ID, Inc. ... Its Newly Formed Advisory Board And Shows First Images of ...
    Cached Biology News:Life Sciences Discovery Fund announces R&D grants 2Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 2Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 3Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 4Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 5Markets Poised for Healthy 2014 as Biometrics Makes Strides in Technology Sector - Company Strengthens Board with Industry's Top Leaders 6
    karyopherin alpha2 (2G7)...
    ... Power Supply is designed specifically ... extensive programming capabilities including eight ... for you to set to ... intuitive PowerEase interface is faster ...
    ... For real-time or pre-programmed liquid ... electrochemistry, or general liquid-handling research ... millisecond accuracy. Run ... Microprocessor-based for accuracy and ...
    ... perfusion system. For real-time or pre-programmed ... electrochemistry, or general liquid-handling research applications. ... accuracy Run experiments automatically - ... and flexibility Turnkey perfusion system ...
    Biology Products: